# COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III

> **NCT04327401** · PHASE3 · TERMINATED · sponsor: **Hospital Sirio-Libanes** · enrollment: 299 (actual)

## Conditions studied

- Coronavirus Infection
- Pneumonia, Viral
- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04327401
- **Lead sponsor:** Hospital Sirio-Libanes
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-13
- **Primary completion:** 2020-07-22
- **Final completion:** 2020-07-22
- **Target enrollment:** 299 (ACTUAL)
- **Why stopped:** The Data Monitoring Committee recommended to stop the trial based on the Recovery Trial results, which was accepted by the CoDEX Steering Committee.
- **Last updated:** 2020-08-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04327401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04327401, "COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04327401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*